Back to Search
APARNA KAMAT, M.D.
M.D.
Gynecologic Oncology Physician
NPI: 1992732887IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
L4481(TX)
CMS Specialties
PrimaryGYNECOLOGICAL ONCOLOGY
Education
OTHER
Class of 1994
Research & Publications (20)
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
PMID 19396818·Cancer·2009
8-other
Erythropoeisis-stimulating agents (ESAs) in cervix cancer: The "black box" paradox.
PMID 19127119·Cancer Biol Ther·2009
8-other
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
PMID 18094433·Clin Cancer Res·2007
7-preclinical
Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
PMID 17542024·Cancer·2007
8-other
Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.
PMID 17363495·Mol Cancer Ther·2007
8-other
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
PMID 17210709·Cancer Res·2007
7-preclinical
Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
PMID 17108216·Ann N Y Acad Sci·2006
8-other
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma.
PMID 16969071·Cancer Biol Ther·2006
7-preclinical
A combination of intravesical BCG [corrected] and [corrected] electromotive mitomycin for high-risk superficial bladder cancer.
PMID 16964186·Nat Clin Pract Urol·2006
8-other
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.
PMID 16551853·Clin Cancer Res·2006
8-other
The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.
PMID 16469571·J Urol·2006
8-other
The merits of vascular targeting for gynecologic malignancies.
PMID 16221381·Curr Oncol Rep·2005
6-review
Validation of criteria used to predict extraprostatic cancer extension: a tool for use in selecting patients for nerve sparing radical prostatectomy.
PMID 16145389·J Urol·2005
4-observational
Protein expression profiling of endometriosis: validation of 2-mm tissue microarrays.
PMID 15589880·Fertil Steril·2004
4-observational
Genetic targeting of relaxin and insulin-like factor 3 receptors in mice.
PMID 15256493·Endocrinology·2004
7-preclinical
Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure.
PMID 15183966·Urology·2004
3-trial
Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha.
PMID 15076299·J Urol·2004
5-case
Antitumor activity of common antibiotics against superficial bladder cancer.
PMID 15028437·Urology·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6550 FANNIN ST, SUITE 901
HOUSTON, TX 77030 - Phone
- (713) 441-1026
Quick Facts
- NPI
- 1992732887
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile